Status:
COMPLETED
Portuguese Observational Survey to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon by Using Elements of the BetaPlus Program - Nurse Support, Auto-injectors
Lead Sponsor:
Bayer
Conditions:
Relapsing Remitting Multiple Sclerosis (RRMS)
Secondary Progressive Multiple Sclerosis (SPMS)
Eligibility:
All Genders
18+ years
Brief Summary
This is an observational survey to assess the factors that influence adherence to Betaferon therapy in multiple sclerosis patients using elements of the BetaPlus support program, including the nurse s...
Eligibility Criteria
Inclusion
- Relapsing-remitting MS (RRMS) or secondary-progressive MS (SPMS)
- Previous treatment with disease modifying drugs
- Adjustment of disease modifying treatment necessary at the discretion of the investigator
- Switch to Betaferon at least 1 month but not longer than 3 months prior to inclusion
Exclusion
- Patients not fulfilling the indications in the local prescribing information
- Refusal to sign inform consent
Key Trial Info
Start Date :
August 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01235455
Start Date
August 1 2007
End Date
May 1 2011
Last Update
November 1 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Portugal